Amy M. Haseley, Ph.D.
Affiliations: | 2012 | Neuroscience | Ohio State University, Columbus, Columbus, OH |
Area:
Neuroscience BiologyGoogle:
"Amy Haseley"Mean distance: 53433
Parents
Sign in to add mentor| Balveen Kaur | grad student | 2012 | Ohio State | |
| (The Effect of the Tumor Microenvironment on Oncolytic Virus Therapy for Glioblastoma.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Yan F, Alinari L, Lustberg ME, et al. (2014) Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma. Cancer Research. 74: 1752-65 |
| Okemoto K, Kasai K, Wagner B, et al. (2013) DNA demethylating agents synergize with oncolytic HSV1 against malignant gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 5952-9 |
| Okemoto K, Wagner B, Meisen H, et al. (2013) STAT3 activation promotes oncolytic HSV1 replication in glioma cells. Plos One. 8: e71932 |
| Currier MA, Eshun FK, Sholl A, et al. (2013) VEGF blockade enables oncolytic cancer virotherapy in part by modulating intratumoral myeloid cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1014-23 |
| Uchida H, Marzulli M, Nakano K, et al. (2013) Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 561-9 |
| Yoo JY, Pradarelli J, Haseley A, et al. (2012) Copper chelation enhances antitumor efficacy and systemic delivery of oncolytic HSV. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 4931-41 |
| Haseley A, Boone S, Wojton J, et al. (2012) Extracellular matrix protein CCN1 limits oncolytic efficacy in glioma. Cancer Research. 72: 1353-62 |
| Yoo JY, Haseley A, Bratasz A, et al. (2012) Antitumor efficacy of 34.5ENVE: a transcriptionally retargeted and "Vstat120"-expressing oncolytic virus. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 287-97 |
| Okemoto K, Wagner BP, Haseley AM, et al. (2012) Abstract 4080: 5-Azacitydine augments the anti-glioma efficacy of Herpes-based oncolytic virotherapy Cancer Research. 72: 4080-4080 |
| Haseley A, Boone S, Kurozumi K, et al. (2010) Abstract 1505: The effect of Cyr61 on oncolytic HSV-1 therapy for glioblastoma multiforme Cancer Research. 70: 1505-1505 |